Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from BSF Enterprise PLC ( (GB:BSFA) ) is now available.
BSF Enterprise PLC has published its Annual Report and Accounts for the year to 30 September 2025, highlighting significant technical and commercial progress across its core subsidiaries 3D Bio-Tissues, Lab-Grown Leather and Kerato, as well as its Hong Kong arm. During the period the group launched its CytoBoost bioactive media additive and expanded City-Mix for cost-effective cultivated meat production, achieved a breakthrough in producing the world’s first 2mm-thick scaffold-free leather and advanced collaborations with luxury fashion brands, and secured a key licensing agreement with the University of Montreal for liquid cornea technology, with veterinary trials targeted for 2026 and human trials for 2027. BSF also strengthened its balance sheet through shareholder approval for up to £15 million in warrant-based fundraising to support commercialisation, spin-outs, Greater China expansion and potential acquisitions, while cutting its net loss to just over £1.0 million through cost control and higher grant income, underscoring its drive to transition from R&D to commercial scale in cultivated meat inputs, lab-grown leather and regenerative medicine.
The most recent analyst rating on (GB:BSFA) stock is a Hold with a £3.00 price target. To see the full list of analyst forecasts on BSF Enterprise PLC stock, see the GB:BSFA Stock Forecast page.
Spark’s Take on GB:BSFA Stock
According to Spark, TipRanks’ AI Analyst, GB:BSFA is a Neutral.
The stock’s overall score is driven by strong technical momentum, despite weak financial performance and valuation concerns. The lack of profitability and negative cash flows are significant risks, but positive price trends provide some optimism.
To see Spark’s full report on GB:BSFA stock, click here.
More about BSF Enterprise PLC
BSF Enterprise PLC is a UK-listed developer and commercialiser of tissue-engineered solutions, focusing on lab-grown leather, cultivated meat and corneal repair technologies. Leveraging a proprietary scaffold-free platform, the company targets sustainable, environmentally responsible alternatives to traditional animal-based materials and regenerative medical products, with a growing presence in markets such as luxury fashion, biopharma and cultivated protein, including expansion into Greater China.
Average Trading Volume: 1,289,486
Technical Sentiment Signal: Strong Sell
Current Market Cap: £2.57M
For detailed information about BSFA stock, go to TipRanks’ Stock Analysis page.